All terms in NCIT
| Label | Id | Description |
|---|---|---|
| FACT-L Version 4 - I Am Sleeping Well | NCIT_C151258 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Functional Well-Being: I am sleeping well.] |
| FACT-L Version 4 - Enjoy Things I Usually Do for Fun | NCIT_C151259 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Functional Well-Being: I am enjoying the things I usually do for fun.] |
| FACT-L Version 4 - I Am Able to Work | NCIT_C151254 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Functional Well-Being: I am able to work (include work at home).] |
| FACT-L Version 4 - My Work Is Fulfilling | NCIT_C151255 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Functional Well-Being: My work (include work at home) is fulfilling.] |
| FACT-L Version 4 - I Am Able to Enjoy Life | NCIT_C151256 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Functional Well-Being: I am able to enjoy life.] |
| FACT-L Version 4 - I Have Accepted My Illness | NCIT_C151257 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Functional Well-Being: I have accepted my illness.] |
| FACT-L Version 4 - I am Forced to Spend Time in Bed | NCIT_C151240 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Physical Well-Being: I am forced to spend time in bed.] |
| FACT-L Version 4 - I Feel Close to My Friends | NCIT_C151241 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Social/Family Well-Being: I feel close to my friends.] |
| FACT-L Version 4 - Get Emotional Support From Family | NCIT_C151242 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Social/Family Well-Being: I get emotional support from my family.] |
| FACT-L Version 4 - I Am Satisfied With My Sex Life | NCIT_C151247 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Social/Family Well-Being: I am satisfied with my sex life.] |
| FACT-L Version 4 - I Feel Sad | NCIT_C151248 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Emotional Well-Being: I feel sad.] |
| FACT-L Version 4 - Satisfied With How I Am Coping | NCIT_C151249 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Emotional Well-Being: I am satisfied with how I am coping with my illness.] |
| FACT-L Version 4 - I Get Support From My Friends | NCIT_C151243 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Social/Family Well-Being: I get support from my friends.] |
| FACT-L Version 4 - My Family Has Accepted My Illness | NCIT_C151244 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Social/Family Well-Being: My family has accepted my illness.] |
| FACT-L Version 4 - Satisfied Communication Illness | NCIT_C151245 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Social/Family Well-Being: I am satisfied with family communication about my illness.] |
| FACT-L Version 4 - I Feel Close to My Partner | NCIT_C151246 | [Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L Version 4) Social/Family Well-Being: I feel close to my partner (or the person who is my main support).] |
| Fluorescence Imaging Agent EMI-137 | NCIT_C126272 | [A water-soluble compound composed of a 26-amino acid cyclic peptide targeting the human hepatocyte growth factor receptor (c-MET) conjugated to a cyanine-based fluorescent dye, with potential fluorescent imaging activity. Upon administration of EMI-137, the peptide moiety specifically targets and binds to the human tyrosine kinase receptor c-Met, which is often overexpressed on cancer cells. Upon imaging, the cancer cells can be visualized.] |
| Imaging Agent | NCIT_C1966 | [A compound that enables or improves the visualization of body structures or functions for medical imaging.] |
| Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777 | NCIT_C126273 | [A cytotoxic recombinant fusion protein consisting of the human cytokine interleukin-2 (IL-2) fused to diphtheria toxin fragments A and B, containing both the catalytic and translocation domains, with potential antineoplastic activity. Upon administration, the IL-2 moiety of diphtheria toxin fragment-IL-2 fusion protein E7777 binds to IL-2 receptors. After internalization by IL-2 receptor-expressing cells via endocytosis, the agent is proteolytically cleaved. This releases the catalytic domain of the toxin moiety, which catalyzes the transfer of the ADP-ribose moiety of NAD to a diphthamide residue of elongation factor 2 (EF-2). This covalent modification inactivates EF-2 and disrupts polypeptide chain elongation, resulting in an inhibition of translation and cell death. E7777 has the same amino acid sequence as denileukin diftitox (DD), but has an increased purity profile and an increased percentage of monomeric, active protein, which improves its efficacy.] |
| Immunotoxin | NCIT_C575 | [Agents comprised of various toxic molecules (Radioactive Isotopes and Bacterial or Plant Toxins) conjugated with specific immune substances (Immunoglobulins, Monoclonal Antibodies, and Antigens) that targets affected cells allowing incorporation of the toxin into the cells.] |